scholarly journals Designing and Analyzing 3D-Printed Personal Steering Controller for Outdoor Electric-Powered Wheelchair Users: A Randomized Controlled Trial on Stroke Patients

2021 ◽  
Vol 11 (6) ◽  
pp. 2743
Author(s):  
Seoyoon Heo ◽  
Wansuk Choi

While the physical conditions of stroke patients are diverse, the joystick-type steering controller of the electric-powered wheelchair (EPW) is almost the same, making the user uncomfortable and not fully utilizing the function of the wheelchair. The purpose of this study was to investigate the effects of the EPW steering controller, specifically the so-called joystick type (3DSC; 3D-printed steering controller, conventional steering controllers; CSC), on surface electromyography (sEMG), Wheelchair Skills Test 4.2 (WST), and QUEST 2.0. The participants were 23 hemiplegic stroke patients (14 males and 9 females) (range 40–65 years) recruited from multi-center process. The 3DSC manufacturing process used a scanner (Precision Laser Probe SLP-500) and a modelling program (SOLIDWORKS 2015). The CSC users’ muscle activities were generally higher than those of the 3DSC users in both males and females (p < 0.05). WST total performance score of CSC is statistically significantly lower than those of 3DSC for both males (3DSC = 49.28 ± 2.19; CSC = 42.85 ± 4.31) (z = −3.935; p < 0.05) and females (3DSC = 48.17 ± 0.44; CSC = 41.11 ± 0.78) (z = −1.910; p < 0.05). QUEST 2.0 scores in CSC (male = 2.40 ± 0.70; female = 2.11 ± 0.78) were significantly lower than those of 3DSC (male = 3.50 ± 0.85; female = 2.90 ± 0.51) in effectiveness categories (p < 0.05). We suggest that 3DSC contributes to reducing the user’s muscle activities and raising the scores of WST performance and QUEST.

2015 ◽  
Vol 96 (11) ◽  
pp. 2017-2026.e3 ◽  
Author(s):  
R. Lee Kirby ◽  
William C. Miller ◽  
Francois Routhier ◽  
Louise Demers ◽  
Alex Mihailidis ◽  
...  

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Francesco Di Gregorio ◽  
Fabio La Porta ◽  
Emanuela Casanova ◽  
Elisabetta Magni ◽  
Roberta Bonora ◽  
...  

Abstract Background Left hemispatial neglect (LHN) is a neuropsychological syndrome often associated with right hemispheric stroke. Patients with LHN have difficulties in attending, responding, and consciously representing the right side of space. Various rehabilitation protocols have been proposed to reduce clinical symptoms related to LHN, using cognitive treatments, or on non-invasive brain stimulation. However, evidence of their benefit is still lacking; in particular, only a few studies focused on the efficacy of combining different approaches in the same patient. Methods In the present study, we present the SMART ATLAS trial (Stimolazione MAgnetica Ripetitiva Transcranica nell’ATtenzione LAteralizzata dopo Stroke), a multicenter, randomized, controlled trial with pre-test (baseline), post-test, and 12 weeks follow-up assessments based on a novel rehabilitation protocol based on the combination of brain stimulation and standard cognitive treatment. In particular, we will compare the efficacy of inhibitory repetitive-transcranial magnetic stimulation (r-TMS), applied over the left intact parietal cortex of LHN patients, followed by visual scanning treatment, in comparison with a placebo stimulation (SHAM control) followed by the same visual scanning treatment, on visuospatial symptoms and neurophysiological parameters of LHN in a population of stroke patients. Discussion Our trial results may provide scientific evidence of a new, relatively low-cost rehabilitation protocol for the treatment of LHN. Trial registration ClinicalTrials.gov NCT04080999. Registered on September 2019.


PM&R ◽  
2009 ◽  
Vol 1 ◽  
pp. S99-S99 ◽  
Author(s):  
Zeev Meiner ◽  
Iris Fisher ◽  
Michal Katz-Leurer ◽  
Martin Neeb ◽  
Anna Sajin ◽  
...  

2021 ◽  
Author(s):  
Rosa Cabanas-Valdés ◽  
Lidia Boix-Sala ◽  
Montserrat Grau-Pellicer ◽  
Juan Antonio Guzmán-Bernal ◽  
Fernanda Maria Caballero-Gómez ◽  
...  

Abstract BackgroundTrunk impairment produces disorders of motor control, balance, and gait that are correlated with increased risk of falls and reduced mobility in stroke survivors. This creates disability and dependency to perform their activities of daily living. Alterations in body alignment occur, requiring treatment strategies focused on improving the postural control. bearing. Core stability exercises (CSE) are a good strategy to improve local strength of trunk, dynamic sitting, standing balance, and gait. There is some evidence about its effectiveness but it is still necessary to run a large multicenter trial to ratify that existing evidence.MethodsThis is a single-blind multicenter randomized controlled trial. Two parallel groups are compared and both perform the same type of therapy. A control group (CG) (n=110) performs conventional physiotherapy (CP) (1 hour per session) focused on improving balance. An experimental group (EG) (n=110) performs CSE (30 minutes) in addition to CP (30 minutes) (1 hour/session in total). EG is divided in two subgroups, in which only half of patients (n=55) perform CSE plus transcutaneous electrical nerve stimulation (TENS). Primary outcome measures are dynamic sitting, assessed by Spanish-version of Trunk Impairment Scale and stepping, assessed by Brunel Balance Assessment. Secondary outcomes are postural control, assessed by Postural Assessment Scale for Stroke patients; standing balance and risk of fall assessed by Berg Balance Scale; gait speed by BTS G-Walk (accelerometer); rate of falls, lower-limb spasticity by Modified Ashworth Scale; activities of daily living by Barthel Index; and quality of life by EQ-5D-5L. These are evaluated at baseline (T0), at 3 weeks (T1), at 5 weeks -at the end of the intervention (T2), at 17 weeks (T3) and at 29 weeks (T4). Study duration per patient is 29 weeks (a 5-week intervention, followed by a 24-week post-intervention). DiscussionThe study will provide useful information on the short and long term effects of a physiotherapy rehabilitation program based on core stability exercises performed in subacute phase.Trial registrationClinicalTrials.gov Identifier NCT03975985. Data registration June 5th, 2019. Retrospectively registered. Date of registration in primary registry: June 5, 2019. Protocol version 1


Sign in / Sign up

Export Citation Format

Share Document